Neuronetics, Inc. Share Price & Technical Analysis
STIM · $1.39 (-10.90%)
Healthcare / Medical Devices
$1.39
-10.90%
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pu…
Price chart
Seasonality
Jun has 2 positive and 3 negative years (last 5 years shown)
7% return in Jun, -12% avg return in past 3 year Jun month.
39% return in 2026, 4% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 50% | -35% | 15% | 27% | -25% | 7% | – | – | – | – | – | – | 39% |
| 25 | 94% | 40% | -16% | 16% | -11% | -12% | 26% | -23% | -18% | 0% | -46% | -7% | 41% |
| 24 | 26% | -12% | 60% | -29% | -44% | -5% | 6% | -50% | -11% | 25% | 0% | 60% | 25% |
| 23 | -14% | -3% | -50% | -21% | 17% | -19% | -9% | -20% | -18% | -21% | 50% | 53% | -55% |
| 22 | -22% | -8% | -12% | -23% | 8% | 14% | 31% | -12% | -11% | 3% | 85% | 10% | 64% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Neutral
Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$111.20M
P/E ratio
—
52W high
$4.85
52W low
$0.80
Volume
17,83,106
Beta
1.13
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹34,400
Abbott Laboratories Cede…
₹32,740
Eli Lilly And Company Ce…
₹28,720
Unitedhealth Group Inc C…
₹17,140
Elevance Health Inc
₹6,770
Frequently asked questions
- What is Neuronetics, Inc. share price today?
- Neuronetics, Inc. (STIM) last traded around $1.39 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does STIM have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for STIM. Download the app for real-time alerts.
- How can I analyze Neuronetics, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.